Genetic variation in α1-antichymotrypsin and its association with Alzheimer's disease

Human Genetics

Volumn 110, Issue 4, 2002, Pages 356-365

  Wang, Xiaoyan ^a   DeKosky, Steven T ^b   Luedecking Zimmer, Erin ^a   Ganguli, Mary ^b   Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMINO ACID;

AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION;

3' UNTRANSLATED REGIONS; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; BASE SEQUENCE; CODON; DNA PRIMERS; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; VARIATION (GENETICS);

EID: 0036556250     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0697-3     Document Type: Article

References (49)

1. 1-antichymotrypsin in brain dysfunction and injury. Res Immunol 143:631-636
2. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501
3. Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53-60
4. Benton AL, Hamsher K, Varney NR, Spreen O (1983) Contributions to Neuropsychological Assessment. A Clinical Manual. Oxford University Press, New York
5. 1-antichymotrypsin A allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry 63:103-105
6. 1-antichymotrypsin gene polymorphism and risk of Alzheimer's disease in the Spanish population. Neurosci Lett 240:107-109
7. 1-antichymotrypsin deficiency in a heterozygote with liver and lung diseases. J Hepatol 18:313-321
8. 1-antichymotrypsin genes on risk for Alzheimer's disease. Am J Med Genet 74:192-194
9. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
10. Ganguli M, Ratcliff G, Huff FJ, Belle S, Kancel MJ, Fischer L, Seaberg EC, Kuller LH (1991) Effects of age, gender, and education on cognitive tests in a rural elderly community sample: Norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology 10:42-52
11. Ganguli M, Ratcliff G, DeKosky ST (1997) Cognitive test scores in community-based older adults with and without dementia. Aging Mental Health 1:176-180
12. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST (2000) Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol 57:824-830
13. 1-antichymotrypsin in a North American population suffering from dementia. J Cereb Blood Flow Metab 17:233-235
14. 1-antichymotrypsin in Alzheimer disease. Genomics 33:53-56
15. 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease. Intern Med 34:481-484
16. 1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. Neurosci Lett 231:56-58
17. 1-antichymotrypsin type A allele in Alzheimer's disease. Neuroreport 8:2639-2643
18. Hughes CP, Berg L, Danzinger WL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572
19. 1-antichymotrypsin polymorphisms with Alzheimer's disease: A report on autopsy-confirmed cases. Exp Neurol 151:237-240
20. Kamboh MI, Aston CE, Hamman RF (1995a) The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 112:145-159
21. 1-antichymotrypsin polymorphism. Nat Genet 10:486-488
22. 1-antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies Distinctions between diseases. Neurology 50:388-391
23. 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis Assoc Disord 9:112-118
24. 1-antichymotrypsin level as a marker for Alzheimer-type dementia. Neurobiol Aging 16:747-753
25. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis-Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST (2000) Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades. Neurology 55:1854-1862
26. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94
27. Mattis S (1976) Mental state examination for organic mental syndrome in the elderly patient. In: Bellak L, Karuso TB (eds) Geriatric Psychiatry. Grune and Stratton, New York
28. Morris JC, Heyman A, Mohs RC, Hughes JP, Van Belle G, Fillenbaum G, Mellitis ED, Clark C (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159-1165
29. 1-antichymotrypsin enhancers Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol 157:2003-2010.
30. 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of apolipoprotein E. Neurology 47:1575-1577
31. 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 103:1205-1210
32. 1-antichymotrypsin A allele and Alzheimer's disease. Neurology 48:1313-1316
33. 1-antichymotrypsin polymorphism in Alzheimer's disease. Ann Neurol 40:678-680
34. 1-antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci 21:1444-1451
35. Nilsson LNG, Das S, Potter H (2000b) Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: Significance for Alzheimer's disease. Neurochem Int 39:361-370
36. Osterreith PA (1944) Le test de copie d'un figure complexe. Arch Psychologie 30:206-356
37. 1-antichymotrypsin gene associated with chronic lung disease. Lancet 339:1538
38. 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 17:740-743
39. Pritchard JK, Stephens M, Donnely P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945-959
40. Rey A (1941) L'exaḿinen psychologie dans les cas d'encephalopathie traumatique. Arch Psychologie 30:286-340
41. 1-antichymotrypsin gene and chronic lung disease. Lancet 342:624
42. Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goate A (1996) Polymorphism in AACT gene may lower age of onset of Alzheimer disease. Neureport 7:534-536
43. Thome J, Baumer A, Kornhuber J, Rosler M, Riederer P (1995) Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm 10:207-212
44. 1-antichymotrypsin variant detected by PCR-single strand conformation polymorphism (PCR-SSCP) and direct sequencing. Hum Genet 90:467-468
45. 1-antichymotrypsin in patients with occlusive-cerebrovascular disease. FEBS Lett 304:66-68
46. Wechsler D (1981) Wechsler Audult Intelligence Scale-Revised. The Psychological Corporation, New York
47. Xie X, Ott J (1993) Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53:A1107
48. 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Ann Neurol 42:115-117
49. Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H, Shoji S (1997) Alzheimer polymorphism in Japanese cases of Alzheimer's disease. J Neurol Sci 152:136-139